These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37347988)

  • 1. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Franco EL;
    Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
    [No Abstract]   [Full Text] [Related]  

  • 2. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
    PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands.
    Schurink-van 't Klooster TM; Siebers AG; Hoes J; van Kemenade FJ; Berkhof J; Bogaards JA; de Melker HE
    Cancer Med; 2023 May; 12(10):11786-11794. PubMed ID: 36965085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for cervical cancer, human papillomavirus (HPV) vaccination].
    Schaff Z; Járay B
    Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV Update: Vaccination, Screening, and Associated Disease.
    McNamara M; Batur P; Walsh JME; Johnson KM
    J Gen Intern Med; 2016 Nov; 31(11):1360-1366. PubMed ID: 27184752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV testing in older women may improve cervical cancer prevention.
    Cancer; 2023 Nov; 129(22):3518. PubMed ID: 37898829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human Papillomavirus: screening of cervical and anal cancers].
    Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
    Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: '2020 list of human papillomavirus assays suitable for primary cervical cancer screening' by Arbyn et al.
    Giuffrè G; Iacobellis M
    Clin Microbiol Infect; 2023 Dec; 29(12):1606-1607. PubMed ID: 37595800
    [No Abstract]   [Full Text] [Related]  

  • 10. Cervical Human Papillomavirus Testing: Current and Future Impact on Patient Care.
    Rizkalla CN; Huang EC
    Surg Pathol Clin; 2024 Sep; 17(3):431-439. PubMed ID: 39129141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Ruan Y; Li H; Liu M; Cao G; Xu X; Han L; Li F
    Cancer Epidemiol; 2023 Jun; 84():102372. PubMed ID: 37119603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Cervical Cancer in Low-Resource African Settings.
    Mulongo M; Chibwesha CJ
    Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk Human Papillomavirus Infection in Putian, China: A Cross-sectional Analysis of 98085 Women.
    Zhang R; Hong G; Liao C; Chen Z; Lin H; Yu L
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):642-646. PubMed ID: 37300259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human papillomavirus (HPV) in cancers.
    Khan A
    S Afr Med J; 2023 Oct; 113(10):10. PubMed ID: 37881906
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.
    Berger L; Wolf-Breitinger M; Weiß C; Tuschy B; Berlit S; Sütterlin M; Spaich S
    Cancer Causes Control; 2023 May; 34(5):469-477. PubMed ID: 36854989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer in Ethiopia: a review of the literature.
    Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
    Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States.
    Downs LS; Nayar R; Gerndt J; Saslow D;
    CA Cancer J Clin; 2023; 73(5):458-460. PubMed ID: 37347977
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.
    Thomsen LT; Kjær SK
    BMC Med; 2021 Jul; 19(1):165. PubMed ID: 34261466
    [No Abstract]   [Full Text] [Related]  

  • 20. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
    Li T; Chen S; Li X; Wu Z; Zhao Y; Cui J; Liu B; Chen F; Zhang X; Qiao Y; Chen W
    Virol J; 2023 Jun; 20(1):116. PubMed ID: 37280665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.